Results 51 to 60 of about 1,214 (101)

[Research progress on calcification mechanism and anti-calcification strategies of vascular grafts]. [PDF]

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi
Su X, Qiu F, Wang H, Han Q.
europepmc   +1 more source

[Expression of the melanoma 2-mediated pyroptosis pathway in peripheral blood mononuclear cells of patients with idiopathic inflammatory myopathies]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban
Chu J, Li P, Tian J, Fu D, Guo L, Sun R, Li Y.   +6 more
europepmc   +1 more source

[Shihu Mixture alleviates diabetic cardiomyopathy in rats by Sirt3-mediated upregulation of myocardial mitochondrial mitophagy pathway]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Lin X, He Y, Shi H, Liu J, Hu H.
europepmc   +1 more source

[A case of toxic shock syndrome secondary to severe bone marrow suppression induced by azathioprine in a patient with autoimmune hepatitis]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Ren Y, Kong M, Huang CY, Bian XQ, Liu HX, Mou DL, Chen Y.   +6 more
europepmc   +1 more source

[Development of a predictive model for severe <i>Mycoplasma</i><i>pneumoniae</i> pneumonia in children younger than 5 years]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Li YT, Long XY, Zhou J, Zhang HY.
europepmc   +1 more source

[Rosa laevigata Michx. inhibits pulmonary arterial smooth muscle cell proliferation in hypertension by modulating the Src-AKT1 axis]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Yang Z, Lü C, Dong Z, Ji S, Bi S, Zhang X, Wang X.   +6 more
europepmc   +1 more source

[Application of Kartogenin in cartilage tissue engineering]. [PDF]

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi
Jiang J, Zhang S, Lu W.
europepmc   +1 more source

[Development and Validation of a Risk Prediction Model for Secondary Pulmonary Infarction in Elderly Patients With Acute Pulmonary Embolism]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Chen S, Weng M, Lü Y, Jiang Y, Pang Y.
europepmc   +1 more source

[Research progress on toxic shock syndrome due to group A <i>Streptococcus</i> infection in children]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Wang HY, Zhou W, Huang LS.
europepmc   +1 more source

[β‑blockers after percutaneous coronary intervention does not reduce risks of all-cause mortality or major adverse cardiovascular events in patients with stable coronary artery disease]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Gao X, Xiao J, Feng N, Guo C, Cao L, Zhang C, Zhang Y, Han T.   +7 more
europepmc   +1 more source